Advertisement
EW vs WST
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EW is a Hold and WST is a Hold.
Momentum Indicator for EW turns positive, indicating new upward trend
EW saw its Momentum Indicator move above the 0 level on October 14, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 88 similar instances where the indicator turned positive. In 60 of the 88 cases, the stock moved higher in the following days. The odds of a move higher are at 68%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where EW's RSI Oscillator exited the oversold zone, 19 of 33 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 58%.
The Moving Average Convergence Divergence (MACD) for EW just turned positive on October 14, 2026. Looking at past instances where EW's MACD turned positive, the stock continued to rise in 28 of 44 cases over the following month. The odds of a continued upward trend are 64%.
Following a +3.32% 3-day Advance, the price is estimated to grow further. Considering data from situations where EW advanced for three days, in 172 of 294 cases, the price rose further within the following month. The odds of a continued upward trend are 59%.
EW may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
EW moved below its 50-day moving average on September 23, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for EW crossed bearishly below the 50-day moving average on September 10, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 15 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 88%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where EW declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 60%.
The Aroon Indicator for EW entered a downward trend on October 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 11 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 47 (best 1 - 100 worst), indicating steady price growth. EW’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 72 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.713) is normal, around the industry mean (10.930). P/E Ratio (51.685) is within average values for comparable stocks, (100.178). Projected Growth (PEG Ratio) (1.852) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (7.974) is also within normal values, averaging (40.124).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EW’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
WST in upward trend: 10-day moving average crossed above 50-day moving average on September 17, 2026
The 10-day moving average for WST crossed bullishly above the 50-day moving average on September 17, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 79%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on WST as a result. In 58 of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 64%.
The Moving Average Convergence Divergence (MACD) for WST just turned positive on October 15, 2026. Looking at past instances where WST's MACD turned positive, the stock continued to rise in 36 of 51 cases over the following month. The odds of a continued upward trend are 71%.
WST moved above its 50-day moving average on September 14, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +2.50% 3-day Advance, the price is estimated to grow further. Considering data from situations where WST advanced for three days, in 201 of 293 cases, the price rose further within the following month. The odds of a continued upward trend are 69%.
Bearish Trend Analysis
The 10-day RSI Indicator for WST moved out of overbought territory on September 25, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 38 similar instances where the indicator moved out of overbought territory. In 22 of the 38 cases, the stock moved lower in the following days. This puts the odds of a move lower at 58%.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where WST declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 58%.
WST broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 13 (best 1 - 100 worst), indicating outstanding price growth. WST’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 21 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 48 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 77 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.842) is normal, around the industry mean (5.011). P/E Ratio (48.099) is within average values for comparable stocks, (163.451). Projected Growth (PEG Ratio) (2.925) is also within normal values, averaging (4.456). Dividend Yield (0.002) settles around the average of (0.005) among similar stocks. P/S Ratio (7.862) is also within normal values, averaging (56.074).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. WST’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.
EW | WST | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 77 | 23 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 85 Overvalued | 77 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 72 | 48 | |
PRICE GROWTH RATING 1..100 | 47 | 13 | |
P/E GROWTH RATING 1..100 | 11 | 21 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
WST's Valuation (77) in the Medical Specialties industry is in the same range as EW (85). This means that WST’s stock grew similarly to EW’s over the last 12 months.
WST's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as EW (100). This means that WST’s stock grew similarly to EW’s over the last 12 months.
WST's SMR Rating (48) in the Medical Specialties industry is in the same range as EW (72). This means that WST’s stock grew similarly to EW’s over the last 12 months.
WST's Price Growth Rating (13) in the Medical Specialties industry is somewhat better than the same rating for EW (47). This means that WST’s stock grew somewhat faster than EW’s over the last 12 months.
EW's P/E Growth Rating (11) in the Medical Specialties industry is in the same range as WST (21). This means that EW’s stock grew similarly to WST’s over the last 12 months.
| EW | WST | |
|---|---|---|
| RSI ODDS (%) | 5 days ago 58% | 3 days ago 58% |
| Stochastic ODDS (%) | 3 days ago 63% | 3 days ago 64% |
| Momentum ODDS (%) | 3 days ago 68% | 3 days ago 64% |
| MACD ODDS (%) | 3 days ago 64% | 3 days ago 71% |
| TrendWeek ODDS (%) | 3 days ago 60% | 3 days ago 68% |
| TrendMonth ODDS (%) | 3 days ago 56% | 3 days ago 69% |
| Advances ODDS (%) | 4 days ago 59% | 3 days ago 69% |
| Declines ODDS (%) | 11 days ago 60% | 11 days ago 58% |
| BollingerBands ODDS (%) | 6 days ago 60% | 3 days ago 67% |
| Aroon ODDS (%) | 3 days ago 72% | N/A |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
EW’s FA Score shows that 1 FA rating(s) are green while WST’s FA Score has 2 green FA rating(s).
- EW’s FA Score: 1 green, 4 red.
- WST’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
EW’s TA Score shows that 5 TA indicator(s) are bullish while WST’s TA Score has 5 bullish TA indicator(s).
- EW’s TA Score: 5 bullish, 5 bearish.
- WST’s TA Score: 5 bullish, 4 bearish.
Price Growth
EW (@Medical/Nursing Services) experienced а +1.63% price change this week, while WST (@Pharmaceuticals: Other) price change was +4.92% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -6.10%. For the same industry, the average monthly price growth was -8.07%, and the average quarterly price growth was -16.10%.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.71%. For the same industry, the average monthly price growth was -3.86%, and the average quarterly price growth was +3.30%.
Reported Earning Dates
EW is expected to report earnings on Nov 04, 2026.
WST is expected to report earnings on Oct 29, 2026.
Industries' Descriptions
@Medical/Nursing Services (-6.10% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
@Pharmaceuticals: Other (-1.71% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
Advertisement
WST and
Correlation & Price change
A.I.dvisor indicates that over the last year, WST has been loosely correlated with STVN. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if WST jumps, then STVN could also see price increases.
| Ticker / NAME | Correlation To WST | 1D Price Change % | ||
|---|---|---|---|---|
| WST | 100% | +0.26% | ||
| STVN - WST | 49% Loosely correlated | -1.82% | ||
| RGEN - WST | 34% Loosely correlated | -4.75% | ||
| QDEL - WST | 33% Loosely correlated | -7.19% | ||
| CAPN - WST | 32% Poorly correlated | -0.18% | ||
| NVST - WST | 32% Poorly correlated | -2.55% | ||
More | ||||